The 3 analysts offering 12-month price forecasts for Bio Rad Laboratories Inc have a median target of 700.00, with a high estimate of 750.00 and a low estimate of 685.00. The median estimate represents a +41.25% increase from the last price of 495.57.
The current consensus among 5 polled investment analysts is to Buy stock in Bio Rad Laboratories Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $2.95
Reporting Date Jul 28
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.